Annual report pursuant to Section 13 and 15(d)

Document and Entity Information

Document and Entity Information - USD ($)
12 Months Ended
Dec. 31, 2022
Mar. 10, 2023
Jun. 30, 2022
Document and Entity Information [Abstract]      
Document Type 10-K    
Document Annual Report true    
Document Period End Date Dec. 31, 2022    
Document Transition Report false    
Entity File Number 001-39811    
Entity Registrant Name Virios Therapeutics, Inc.    
Entity Incorporation, State or Country Code DE    
Entity Tax Identification Number 85-4314201    
Entity Address, Address Line One 44 Milton Avenue    
Entity Address, City or Town Alpharetta    
Entity Address State Or Province GA    
Entity Address, Postal Zip Code 30009    
City Area Code 866    
Local Phone Number 620-8655    
Title of 12(b) Security Common Stock, $0.0001 Par Value per Share    
Trading Symbol VIRI    
Security Exchange Name NASDAQ    
Entity Well-known Seasoned Issuer No    
Entity Voluntary Filers No    
Entity Current Reporting Status Yes    
Entity Interactive Data Current Yes    
Entity Filer Category Non-accelerated Filer    
Entity Small Business true    
Entity Emerging Growth Company true    
Entity Ex Transition Period false    
Entity Shell Company false    
ICFR Auditor Attestation Flag false    
Entity Public Float     $ 31,229,227.08
Entity Common Stock, Shares Outstanding   18,330,390  
Entity Central Index Key 0001818844    
Current Fiscal Year End Date --12-31    
Document Fiscal Year Focus 2022    
Document Fiscal Period Focus FY    
Amendment Flag false    
Auditor Name FORVIS, LLP (Formerly, Dixon Hughes Goodman LLP)    
Auditor Firm ID 686    
Auditor Location Atlanta, Georgia